1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

ENT 2019

Discussion in 'Olympus' started by alwaysquestion34, Jan 7, 2019 at 12:29 AM.

  1. alwaysquestion34

    alwaysquestion34 new user

    Dec 30, 2018
    Likes Received:
    Considering Olympus. Lot's of shit talking here. That's all.